United States Food and Drug Administration (USFDA) has concluded inspection at the Unichem Laboratories’ Active Pharmaceutical Ingredients (APIs) facility at Roha. The inspection was conducted from September 9, 2019 to September 12, 2019. The inspection was a post approval inspection and successfully concluded without any FDA form 483 issued.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.